Clinical Research Directory
Browse clinical research sites, groups, and studies.
Corneal Crosslinking for Treatment of Corneal Neovascularization
Sponsor: Price Vision Group
Summary
The study objective is to assess safety and efficacy of photo-activation of riboflavin for treatment of corneal neovascularization with or without concomitant inflammation and/or infection.
Official title: Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Corneal Neovascularization With or Without Concomitant Inflammation and/or Infection
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
62
Start Date
2021-05-03
Completion Date
2026-09-15
Last Updated
2025-07-31
Healthy Volunteers
No
Conditions
Interventions
30 minute photoactivation of riboflavin 0.1%
Use of riboflavin 0.1% eye drops and 3mW/cm2 UVA light for 30 minutes
10 minute photoactivation of riboflavin 0.1%
Use of riboflavin 0.1% eye drops and 9mW/cm2 UVA light for 10 minutes
Locations (1)
Price Vision Group
Indianapolis, Indiana, United States